Surgepays Stock Analysis

SURG Stock  USD 1.98  0.03  1.54%   
Surgepays is undervalued with Real Value of 4.63 and Target Price of 13.0. The main objective of Surgepays stock analysis is to determine its intrinsic value, which is an estimate of what Surgepays is worth, separate from its market price. There are two main types of Surgepays' stock analysis: fundamental analysis and technical analysis.
The Surgepays stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Surgepays' ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.

Surgepays Stock Analysis Notes

About 32.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.13. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgepays has Price/Earnings To Growth (PEG) ratio of 0.53. The entity recorded a loss per share of 1.18. The firm had not issued any dividends in recent years. Surgepays had 1:50 split on the 2nd of November 2021. SurgePays, Inc., a financial technology and telecommunications company, provides services to the underbanked community in the United States. Further, it operates a bilingual operations center offering the Company with sales support, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, and other various operational support services. Surgepays operates under SoftwareApplication classification in the United States and is traded on NASDAQ Exchange. It employs 32 people. To find out more about Surgepays contact Kevin Cox at 901 302 9587 or learn more at https://surgepays.com.

Surgepays Quarterly Total Revenue

4.77 Million

Surgepays Investment Alerts

Surgepays is way too risky over 90 days horizon
Surgepays may become a speculative penny stock
Surgepays appears to be risky and price may revert if volatility continues
About 32.0% of the company outstanding shares are owned by corporate insiders
Latest headline from simplywall.st: Investors Appear Satisfied With SurgePays, Inc.s Prospects As Shares Rocket 25

Surgepays Upcoming and Recent Events

4th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Surgepays Largest EPS Surprises

Earnings surprises can significantly impact Surgepays' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-06-30
2015-06-300.040.050.0125 
2014-12-31
2014-12-310.020.030.0150 
2014-09-30
2014-09-300.020.030.0150 
View All Earnings Estimates

Surgepays Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Corsair Capital Management Llc2024-09-30
29.9 K
Cetera Investment Advisers2024-09-30
22.2 K
Two Sigma Securities, Llc2024-09-30
19.3 K
Royce & Associates, Lp2024-09-30
18.6 K
Advisor Group Holdings, Inc.2024-06-30
16.6 K
James Investment Research, Inc.2024-09-30
13 K
Goss Wealth Management Llc2024-09-30
13 K
Susquehanna International Group, Llp2024-09-30
12.1 K
Simplex Trading, Llc2024-09-30
K
Vanguard Group Inc2024-09-30
587 K
Cable Car Capital Llc2024-09-30
515 K
Note, although Surgepays' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Surgepays Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 37.5 M.

Surgepays Profitablity

The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.72) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.72.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.55  0.58 
Return On Capital Employed 0.65  0.68 
Return On Assets 0.49  0.52 
Return On Equity 0.73  0.69 

Management Efficiency

Surgepays has return on total asset (ROA) of (0.0151) % which means that it has lost $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0519) %, meaning that it created substantial loss on money invested by shareholders. Surgepays' management efficiency ratios could be used to measure how well Surgepays manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Surgepays' Return On Assets are most likely to increase significantly in the upcoming years. At this time, Surgepays' Non Current Assets Total are most likely to increase significantly in the upcoming years. The Surgepays' current Non Currrent Assets Other is estimated to increase to about 213.5 K, while Intangible Assets are projected to decrease to roughly 2 M.
Last ReportedProjected for Next Year
Book Value Per Share 1.99  3.96 
Tangible Book Value Per Share 1.69  3.06 
Enterprise Value Over EBITDA 4.12  4.33 
Price Book Value Ratio 3.26  3.42 
Enterprise Value Multiple 4.12  4.33 
Price Fair Value 3.26  3.42 
Enterprise Value82.8 M86.9 M
The strategic initiatives led by Surgepays' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Operating Margin
(0.72)
Profit Margin
(0.01)
Beta
1.392
Return On Assets
(0.02)
Return On Equity
(0.05)

Technical Drivers

As of the 3rd of December, Surgepays has the Coefficient Of Variation of 1405.38, risk adjusted performance of 0.0631, and Semi Deviation of 5.11. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgepays, as well as the relationship between them. Please validate Surgepays information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Surgepays is priced more or less accurately, providing market reflects its prevalent price of 1.98 per share. Please also confirm Surgepays total risk alpha, which is currently at (0.49) to double-check the company can sustain itself at a future point.

Surgepays Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Surgepays middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Surgepays. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Surgepays Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgepays insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgepays' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgepays insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Weisberg Laurie over a week ago
Acquisition by Weisberg Laurie of 301 shares of Surgepays at 1.83 subject to Rule 16b-3
 
Kevin Cox over three weeks ago
Disposition of 31700 shares by Kevin Cox of Surgepays at 1.595 subject to Rule 16b-3
 
Evers Anthony George over a month ago
Disposition of 36667 shares by Evers Anthony George of Surgepays at 1.6 subject to Rule 16b-3
 
Evers Anthony George over two months ago
Disposition of 36667 shares by Evers Anthony George of Surgepays at 1.5376 subject to Rule 16b-3
 
Evers Anthony George over two months ago
Acquisition by Evers Anthony George of 66667 shares of Surgepays subject to Rule 16b-3
 
Schurfeld Richard Earl over two months ago
Discretionary transaction by Schurfeld Richard Earl of tradable shares of Surgepays subject to Rule 16b-3
 
Evers Anthony George over two months ago
Disposition of tradable shares by Evers Anthony George of Surgepays at 3.0 subject to Rule 16b-3
 
Schurfeld Richard Earl over two months ago
Acquisition by Schurfeld Richard Earl of 1800 shares of Surgepays at 1.5 subject to Rule 16b-3
 
Schurfeld Richard Earl over two months ago
Disposition of 22900 shares by Schurfeld Richard Earl of Surgepays at 0.0092 subject to Rule 16b-3
 
Schurfeld Richard Earl over two months ago
Disposition of 100 shares by Schurfeld Richard Earl of Surgepays at 0.03 subject to Rule 16b-3
 
Kevin Cox over three months ago
Disposition of 35100 shares by Kevin Cox of Surgepays at 1.4782 subject to Rule 16b-3
 
Kevin Cox over three months ago
Acquisition by Kevin Cox of 83333 shares of Surgepays subject to Rule 16b-3

Surgepays Outstanding Bonds

Surgepays issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Surgepays uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Surgepays bonds can be classified according to their maturity, which is the date when Surgepays has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Surgepays Predictive Daily Indicators

Surgepays intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Surgepays stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Surgepays Forecast Models

Surgepays' time-series forecasting models are one of many Surgepays' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Surgepays' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Surgepays Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Surgepays prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Surgepays shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Surgepays. By using and applying Surgepays Stock analysis, traders can create a robust methodology for identifying Surgepays entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.13  0.14 
Operating Profit Margin 0.14  0.14 
Net Profit Margin 0.15  0.16 
Gross Profit Margin 0.26  0.27 

Current Surgepays Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Surgepays analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Surgepays analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
13.0Buy2Odds
Surgepays current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Surgepays analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Surgepays stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Surgepays, talking to its executives and customers, or listening to Surgepays conference calls.
Surgepays Analyst Advice Details

Surgepays Stock Analysis Indicators

Surgepays stock analysis indicators help investors evaluate how Surgepays stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Surgepays shares will generate the highest return on investment. By understating and applying Surgepays stock analysis, traders can identify Surgepays position entry and exit signals to maximize returns.
Begin Period Cash FlowM
Total Stockholder Equity28.2 M
Capital Lease Obligations399.4 K
Property Plant And Equipment Net749.7 K
Cash And Short Term Investments14.6 M
Cash14.6 M
50 Day M A1.7359
Net Interest Income-596 K
Total Current Liabilities12.7 M
Forward Price Earnings8
Investments-281.3 K
Interest Expense596 K
Stock Based Compensation529.5 K
Long Term Debt460.5 K
Common Stock Shares Outstanding14.9 M
Tax Provision-2.3 M
Quarterly Earnings Growth Y O Y-0.777
Free Cash Flow10 M
Other Current Assets161.9 K
Accounts Payable6.4 M
Net Debt-9.2 M
Other Operating Expenses118.3 M
Non Current Assets Total8.6 M
Liabilities And Stockholders Equity41.9 M
Non Currrent Assets Other176.9 K

Complementary Tools for Surgepays Stock analysis

When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stocks Directory
Find actively traded stocks across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios